Syneron Medical said today it won FDA 510(k) clearance for a new ultra-short 785nm wavelength laser for its PicoWay picosecond laser device. The PicoWay system is an aesthetic laser system designed for removing tattoos of all colors and types and treating pigmented lesions. The system won FDA clearance for the removal of tattoos in November, […]
Syneron Medical Ltd.
SEMDA taps AdvaMed’s Jason Rupp for executive director role |Personnel Moves
Syneron names new CEO, beats The Street and buys New Star Lasers
Israeli device maker Syneron Medical Ltd. (NSDQ:ELOS) made some major moves this month, announcing a new CEO alongside strong Q4 earnings and signing a deal to acquire New Lasers Inc.
Syneron, Iluminage land expanded indication on hair removal system
Iluminage Beauty, the joint venture between Unilever Ventures & Syneron Medical Ltd. (NSDQ:ELOS), won expanded indication from the FDA for its "me" brand of home-use hair removal products.
Cambridge Heart chairman, ex-CEO both resign | Personnel Moves
Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.
Syneron, Unilever Ventures make joint venture Iluminage Beauty
Syneron Medical Ltd. (NSDQ:ELOS) stock surged by 16% for the week after its subsidiary, Syneron Beauty, said it will partner with Unilever Ventures’s Iluminage Inc., on a joint venture, to be called Iluminage Beauty.
Syneron lands 510(k), CE Mark for VelaShape III
Syneron Medical Ltd. (NSDQ:ELOS) said it won a pair of regulatory nods for its VelaShape III "body shaping" device.
Syneron takes a hit on Q2 stumble
Syneron Medical Ltd. (NSDQ:ELOS) stumbled during the 2nd quarter, posting earnings that were even with Wall Street’s forecast but just missing sales expectations, sending share prices down this week.
Syneron lands Korean approval for skin-lightening product
Israel-based aesthetic device company Syneron Medical (NSDQ:ELOS) landed Korean regulatory approval for its elure skin-lightening product, a victory the company touts as crucial in a high-demand market.
Jawbone agrees to pony up more than $100M for BodyMedia’s wearable sensors | Wall Street Beat
Jawbone agreed to acquire BodyMedia, reportedly for more than $100 million, in a bid to expand its footprint in the wearable technology market.
San Francisco-based Jawbone did not disclose the deal’s value, but Reuters, citing "a person familiar with the matter," reported that it’s worth "north of $100 million."
Pittsburgh-based BodyMedia’s roughly 60 employees will "join Jawbone’s existing team," according to a press release.
Syneron CEO Scafuri steps down, replaced by co-founder Eckhouse
After 4 years at the helm of Yokham, Israel-based Syneron Medical (NSDQ:ELOS), Louis Scafuri is walking away from the corner office of the aesthetic medical device company effective immediately.
Co-founder Shimon Eckhouse, who served as Syneron CEO from its founding in 1992 to 1999, was tapped to replace the outgoing Scafuri. Eckhouse will also serve as chairman, according to a press release.